Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease leukemia
Phenotype C0019829|hodgkin lymphoma
Sentences 3
PubMedID- 23295809 Risk of therapy-related secondary leukemia in hodgkin lymphoma: the stanford university experience over three generations of clinical trials.
PubMedID- 22708037 The risk of therapy-related myelodysplasia/acute myeloid leukemia in hodgkin lymphoma has substantially decreased in the abvd era abolishing mechlorethamine and procarbazine and limiting volumes and doses of radiotherapy.
PubMedID- 23497375 There is ample evidence linking notch and hematologic malignancies, including hodgkin and non-hodgkin lymphomas, subsets of acute myeloid leukemia, and b-cell chronic lymphoid leukemia [16-18].

Page: 1